Using cancer registries to supplement clinical trial data and inform regulatory decision.

Authors :: da Costa FA
da Costa Miranda A
Source :: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2020 Oct; Vol. 29 (10), pp. 1319-1321. Date of Electronic Publication: 2019 Dec 01.
Publication Year :: 2020

Subjects :: Antineoplastic Agents economics
Clinical Trials as Topic economics
Clinical Trials as Topic statistics & numerical data
Decision Making, Organizational
Drug Approval economics
Drug Costs
Humans
Neoplasms economics
Treatment Outcome
Antineoplastic Agents therapeutic use
Data Collection methods
Drug Approval organization & administration
Neoplasms drug therapy
Registries statistics & numerical data

Full Text Access

Tools